Is TAALF or MRK a better dividend investment in 2026?

TAALF currently yields 266.67% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: TAALF offers higher current income.

What is the dividend yield difference between TAALF and MRK?

TAALF has a forward dividend yield of 266.67% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 263.91 percentage points.

Home › Compare › TAALF vs MRK

TAALF vs MRK: Dividend Comparison 2026

TAALF yields 266.67% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TAALF wins by $696.12M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TAALF

● Live price

266.67%

Share price

$0.75

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$696.17M

Annual income

$400,633,988.24

Full TAALF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — TAALF vs MRK

📍 TAALF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TAALF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TAALF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TAALF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TAALF

Annual income on $10K today (after 15% tax)

$22,666.67/yr

After 10yr DRIP, annual income (after tax)

$340,538,890.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, TAALF beats the other by $340,530,561.59/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TAALF + MRK for your $10,000?

TAALF: 50%MRK: 50%

100% MRK50/50100% TAALF

Portfolio after 10yr

$348.12M

Annual income

$200,321,893.19/yr

Blended yield

57.54%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TAALF

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TAALF buys

MRK buys

No recent congressional trades found for TAALF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTAALFMRK

Forward yield	266.67% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$696.17M ✓	$56.8K
Annual income after 10y	$400,633,988.24 ✓	$9,798.13
Total dividends collected	$665.34M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: TAALF vs MRK ($10,000, DRIP)

Year	TAALF Portfolio	TAALF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$37,367	$26,666.67	$11,206	$366.19	+$26.2K → TAALF
2	$133,108	$93,125.65	$12,650	$502.35	+$120.5K → TAALF
3	$452,457	$310,031.11	$14,407	$694.19	+$438.1K → TAALF
4	$1,469,034	$984,905.08	$16,585	$967.82	+$1.45M → TAALF
5	$4,560,449	$2,988,583.40	$19,342	$1,363.89	+$4.54M → TAALF
6	$13,550,447	$8,670,766.49	$22,913	$1,947.19	+$13.53M → TAALF
7	$38,576,939	$24,077,960.70	$27,662	$2,823.89	+$38.55M → TAALF
8	$105,340,736	$64,063,410.85	$34,159	$4,173.35	+$105.31M → TAALF
9	$276,205,967	$163,491,379.88	$43,337	$6,308.80	+$276.16M → TAALF
10	$696,174,373	$400,633,988.24	$56,776	$9,798.13	+$696.12M → TAALF

TAALF vs MRK: Complete Analysis 2026

TAALF — Stock

TAAL Distributed Information Technologies Inc. owns and manages professional-grade blockchain infrastructure based on SHA-256 Bitcoin protocol. Its blockchain infrastructure provides value-added services to support and enable businesses to build customized blockchain-based solutions and applications for enterprise clients. The company also provides transaction processing and digital asset tokenization services. It serves the supply chain, financial services, health care, and gaming and media sectors. The company was formerly known as Squire Mining Ltd. and changed its name to TAAL Distributed Information Technologies Inc. in December 2019. TAAL Distributed Information Technologies Inc. was incorporated in 2011 and is headquartered in Toronto, Canada.

Full TAALF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this TAALF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TAALF vs SCHD TAALF vs JEPI TAALF vs O TAALF vs KO TAALF vs MAIN TAALF vs JNJ TAALF vs ABBV TAALF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.